Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON36631
NL-OMON36631
Not yet recruiting
Not Applicable

Hypothalamic serotonin transporters in subjects suspect for hypothalamic damage - HypS-study

Academisch Medisch Centrum0 sites18 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionshypothalamic damagehypothalamic dysfunction10021112

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
hypothalamic damage
Sponsor
Academisch Medisch Centrum
Enrollment
18
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •having pituitary insufficiency and suspicion of hypothalamic damage
  • •or having pituitary insufficiency and no suspicion of hypothalamic damage
  • •or (in case of controls) being healthy
  • •age between 18\-75 years old

Exclusion Criteria

  • •\*Unwilling or unable to provide informed consent
  • •\*Serious neuropsychiatric problems
  • •\*Use of medication which interferes with serotonin metabolism (e.g. psychotropic medication like SSRIs or other antidepressants) and dopamin metabolism
  • •\*Life\-time ecstasy, amphetamine or cocaine use
  • •\*Intravenous drug abuse
  • •\*Participation in another study associated with exposure to ionizing radiation during the last 12 months
  • •\*Pregnancy
  • •\*Contra\-indication for MRI

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Hypothalame serotonine transsporters in mensen verdacht voor hypothalame schade.hypothalamic dysfunctionhypothalamic damagepituitary insufficiencyhypothalame schadehypothalame dysfunctiehypofyse-insufficientie
NL-OMON20258Academic Medical Center, AmsterdamMeibergdreef 91105 AZ Amsterdam18
Recruiting
Not Applicable
A PET study of serotonin transporter, activated microglia and energy metabolism measerment of the brain in Chronic Fatigue Syndrome.Chronic Fatigue Syndrome
JPRN-UMIN000005469Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduated School of Medicine48
Active, not recruiting
Not Applicable
ongitudinal imaging of serotonin transporter occupancy using PET and [11C]DASB in patients with major depression treated with escitalopram or citalopram - PET with DASB comparing escitalopram to citalopramMajor depression
EUCTR2006-006576-38-ATSiegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien
Recruiting
Not Applicable
The relationship of serotonin-transporter polymorphism and early life events with endophenotypes of depression and anxietydepressionmood disorder10027946
NL-OMON32167niversiteit Leiden500
Completed
Not Applicable
Imaging serotonin transmission in the brain of depressed patients.Major depressive disorder, Adjustment disorder with depression
JPRN-UMIN000012050ational Institute of Radiological Sciences60